Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$13.06 - $15.0 $42,366 - $48,660
-3,244 Reduced 4.02%
77,397 $1.14 Million
Q4 2023

Feb 14, 2024

SELL
$12.02 - $13.41 $913,664 - $1.02 Million
-76,012 Reduced 48.52%
80,641 $1.08 Million
Q3 2023

Nov 14, 2023

BUY
$11.6 - $12.52 $963,240 - $1.04 Million
83,038 Added 112.8%
156,653 $1.93 Million
Q2 2023

Aug 11, 2023

SELL
$12.02 - $13.07 $785,867 - $854,516
-65,380 Reduced 47.04%
73,615 $905,000
Q1 2023

May 16, 2023

SELL
$11.35 - $12.32 $1.32 Million - $1.43 Million
-116,341 Reduced 45.56%
138,995 $1.71 Million
Q4 2022

Feb 14, 2023

BUY
$3.68 - $12.51 $786,482 - $2.67 Million
213,718 Added 513.52%
255,336 $2.93 Million
Q3 2022

Nov 14, 2022

BUY
$3.7 - $6.06 $10,622 - $17,398
2,871 Added 7.41%
41,618 $156,000
Q2 2022

Aug 15, 2022

BUY
$4.89 - $7.13 $4,973 - $7,251
1,017 Added 2.7%
38,747 $231,000
Q1 2022

May 16, 2022

BUY
$3.75 - $6.82 $39,116 - $71,139
10,431 Added 38.21%
37,730 $239,000
Q4 2021

Feb 14, 2022

SELL
$3.75 - $5.1 $54,461 - $74,067
-14,523 Reduced 34.73%
27,299 $107,000
Q2 2021

Aug 11, 2021

SELL
$6.04 - $7.77 $389,622 - $501,219
-64,507 Reduced 60.67%
41,822 $267,000
Q1 2021

May 17, 2021

BUY
$6.15 - $8.7 $177,839 - $251,577
28,917 Added 37.35%
106,329 $668,000
Q4 2020

Feb 16, 2021

BUY
$3.69 - $8.31 $20,402 - $45,945
5,529 Added 7.69%
77,412 $533,000
Q3 2020

Nov 16, 2020

BUY
$3.1 - $4.3 $95,597 - $132,603
30,838 Added 75.13%
71,883 $288,000
Q2 2020

Aug 14, 2020

SELL
$2.21 - $3.88 $92,506 - $162,409
-41,858 Reduced 50.49%
41,045 $137,000
Q1 2020

May 15, 2020

SELL
$1.63 - $3.58 $105,255 - $231,174
-64,574 Reduced 43.79%
82,903 $178,000
Q4 2019

Feb 14, 2020

BUY
$3.15 - $4.67 $402,299 - $596,424
127,714 Added 646.23%
147,477 $465,000
Q2 2018

Aug 14, 2018

BUY
$3.86 - $7.61 $13,598 - $26,810
3,523 Added 21.69%
19,763 $97,000
Q4 2017

Feb 14, 2018

BUY
$7.99 - $11.87 $129,757 - $192,768
16,240
16,240 $166,000

Others Institutions Holding MACK

About MERRIMACK PHARMACEUTICALS INC


  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.